Which blood biomarkers actually matter for longevity?

Short answer: several routinely measured blood biomarkers track processes known to drive aging and predict morbidity/mortality — inflammation, metabolic health (glucose/insulin), lipids/atherosclerotic risk, organ-function markers (kidney, liver), nutritional status, and some endocrine/aging-specific markers. Focus on markers that are actionable (you can change them with lifestyle, meds, or supplements) and well-validated for risk prediction.

Key biomarkers that matter for longevity (what they indicate and why)

• HbA1c and fasting glucose

  • Why: chronic hyperglycemia and insulin resistance strongly predict cardiovascular disease, dementia, and mortality.
  • What to watch for/action: keep HbA1c in the normal/near-normal range (individual targets vary). Improve with diet, activity, weight loss, sleep and meds when needed.

• Fasting insulin and HOMA-IR (insulin resistance)

  • Why: insulin resistance predicts metabolic dysfunction even before glucose rises.
  • Actionable: improves with same lifestyle measures as above.

• Lipid panel: LDL-C, HDL-C, triglycerides

  • Why: LDL and triglyceride-rich particles drive atherosclerosis, the main driver of cardiovascular death.
  • Actionable: lifestyle, statins or other lipid-lowering therapy when indicated.

• ApoB and Lipoprotein(a) [Lp(a)]

  • Why: ApoB is a better measure of atherogenic particle burden than LDL-C alone; Lp(a) is a genetically determined independent risk factor.
  • Actionable: ApoB helps guide therapy intensity; Lp(a) is mostly genetic but new therapies are emerging and high Lp(a) may change screening/therapy decisions.

• High-sensitivity C-reactive protein (hs-CRP) and, when available, IL-6

  • Why: systemic inflammation is strongly linked to risk of many age-related diseases and mortality.
  • Actionable: lowers with weight loss, exercise, smoking cessation, some meds (e.g., statins lower hs-CRP).

• Kidney function: creatinine, eGFR, cystatin C, urine albumin-to-creatinine ratio

  • Why: reduced renal function is a major predictor of mortality and limits treatment options.
  • Actionable: blood pressure control, glucose control, and addressing nephrotoxic exposures.

• Liver enzymes: ALT, AST, GGT

  • Why: nonalcoholic fatty liver disease and liver dysfunction associate with metabolic disease and mortality.
  • Actionable: weight loss, diet, alcohol moderation.

• Complete blood count (CBC) — hemoglobin, hematocrit, white count, platelet count, and derived ratios (neutrophil/lymphocyte)

  • Why: anemia, chronic inflammation, or abnormal counts predict worse outcomes in older adults.
  • Actionable: treat underlying causes (iron/B12/folate deficiency, inflammation, marrow disease).

• Serum albumin and total protein

  • Why: low albumin in older adults is a robust predictor of frailty and mortality (marker of nutrition and chronic disease).
  • Actionable: evaluate nutrition, inflammation, liver/kidney disease.

• Vitamin D (25-hydroxy), vitamin B12, methylmalonic acid (if B12 borderline), and ferritin/iron studies

  • Why: deficiencies are common, treatable, and affect bone, cognition, and hematologic health.
  • Actionable: supplementation when indicated; correct causes of deficiency.

• Homocysteine

  • Why: elevated levels associate with cardiovascular risk and cognitive decline; often responsive to B vitamin repletion.
  • Actionable: treat B-vitamin deficiencies if elevated.

• Cardiac markers (when clinically appropriate): NT-proBNP, high-sensitivity troponin

  • Why: predict heart failure and cardiac risk even before symptoms.
  • Actionable: guide cardiology evaluation and risk management.

• Kidney and metabolic waste: uric acid

  • Why: high uric acid links to gout, metabolic disease, and some observational risk for cardiovascular disease.
  • Actionable: diet, medications if symptomatic or very high.

Markers with promise but more specialized / interpret with caution

• IGF‑1
  • Complex: low IGF-1 is associated with frailty in older adults, but lower GH/IGF signaling is associated with increased lifespan in animal models. Interpret in clinical context.
• Telomere length and DNA methylation (epigenetic) clocks
  • Why: correlate with biological age in population studies.
  • Limits: they are interesting research/monitoring tools but not yet proven to reliably guide interventions for extending human lifespan.
• Broad metabolomics, proteomics, advanced inflammatory panels
  • Why: powerful research tools; generally not necessary for routine longevity assessment.

What to test as a practical baseline (frequency)

• Annual/core: CBC, CMP (includes creatinine, liver enzymes, electrolytes, albumin), lipid panel, HbA1c (or annual if normal), hs‑CRP, vitamin D 25‑OH, TSH (thyroid screen), vitamin B12, ferritin (or iron studies) — more often if abnormal.
• Every 1–3 years or if risk warrants: ApoB and/or advanced lipid testing (if cardiovascular risk), Lp(a) once (genetic), fasting insulin/HOMA-IR (if metabolic risk), urine albumin-to-creatinine (if diabetes or HTN), NT-proBNP/troponin if cardiac risk.
• Consider specialized tests (cystatin C, homocysteine, epigenetic age, metabolomics) for deeper evaluation or research interest.

How to act: focus on interventions that reliably improve multiple biomarkers and outcomes — smoking cessation, healthy diet (Mediterranean/plant-forward), maintain healthy weight, regular aerobic and resistance exercise, good sleep, stress reduction, blood pressure control, glucose control, and guideline-directed medications when indicated (statins, antihypertensives, diabetes meds).

Where to get testing and interpretation (brands/services)

• Basic/broad testing:
  • Quest Diagnostics or Labcorp — large national labs that run standard panels and many specialty tests.
  • Everlywell or Walk-In Lab — options for consumer-initiated testing (availability varies by test/state).
• Longevity-focused interpretation and personalized plans:
  • InsideTracker — integrates blood biomarkers with actionable lifestyle recommendations and evidence-based target ranges.
  • WellnessFX (or similar clinical wellness services) — medical review plus interpretation and coaching.
• Continuous glucose monitoring (for metabolic insight):
  • Levels — CGM plus app interpretation focused on metabolic health (diet/activity feedback).
• Advanced/specialty tests:
  • SpectraCell — micronutrient testing (if you suspect deficits).
  • Cleveland HeartLab or similar cardiometabolic specialty labs — for advanced inflammatory and cardiac risk markers.
• Epigenetic/biological-age tests (if you want a biological-age baseline):
  • TruDiagnostic, Chronomics, or other epigenetic age services — useful for tracking but interpret cautiously.

Final notes

• Prioritize markers that are actionable and linked to clear interventions: glucose control, lipids/ApoB, inflammation (hs‑CRP), kidney function, and vitamin/nutrient deficiencies.
• Targets must be individualized based on age, sex, comorbidities, and risk — discuss results and treatment decisions with your primary care doctor or a clinician who focuses on cardiovascular/aging medicine.
• If you want, tell me your age, sex, major medical history, and any recent labs you have and I can highlight the most important markers for you and suggest a practical test panel and frequency.